A pilot study of the safety and effects of the matrix metalloproteinase inhibitor marimastat in gastric cancer (Q73008368)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492628%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

A pilot study of the safety and effects of the matrix metalloproteinase inhibitor marimastat in gastric cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492628%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492628%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

G M Tierney

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492628%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

N R Griffin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492628%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

R C Stuart

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492628%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

H Kasem

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492628%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

K P Lynch

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492628%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J T Lury

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492628%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

P D Brown

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492628%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

A W Millar

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492628%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

S L Parsons

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492628%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 April 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492628%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

31 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492628%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492628%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492628%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

563-568

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492628%20AND%20SRC:MED&resulttype=core&format=json

Is there an epidemic of cancer?

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900007-6

7 January 2021

Improving the detection rate of early gastric cancer requires more than open access gastroscopy: a five year study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900007-6

7 January 2021

Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. North Central Cancer Treatment Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900007-6

7 January 2021

5-fluorouracil vs. epirubicin vs. 5-fluorouracil plus epirubicin in advanced gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900007-6

7 January 2021

Metalloproteinases and their inhibitors in matrix remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900007-6

7 January 2021

Oral administration of a matrix metalloproteinase inhibitor, CGS 27023A, protects the cartilage proteoglycan matrix in a partial meniscectomy model of osteoarthritis in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900007-6

7 January 2021

Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900007-6

7 January 2021

Matrix metalloproteinases in brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900007-6

7 January 2021

Matrix metalloproteinase-7 expression in gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900007-6

7 January 2021

Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900007-6

7 January 2021

Plasma concentration of matrix metalloproteinase 9 in gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900007-6

7 January 2021

Matrix metalloproteinase inhibition: a review of anti-tumour activity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900007-6

7 January 2021

Results of single and repeat dose studies of the oral matrix metalloproteinase inhibitor marimastat in healthy male volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900007-6

7 January 2021

Marimastat in recurrent colorectal cancer: exploratory evaluation of biological activity by measurement of carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900007-6

7 January 2021

Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900007-6

7 January 2021

Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900007-6

7 January 2021

10.1016/S0959-8049(99)00007-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492628%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference